Brown Advisory Inc Ascendis Pharma A/S Transaction History
Brown Advisory Inc
- $77.3 Billion
- Q3 2024
A detailed history of Brown Advisory Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Brown Advisory Inc holds 467,652 shares of ASND stock, worth $65.3 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
467,652
Previous 478,676
2.3%
Holding current value
$65.3 Million
Previous $65.3 Million
6.98%
% of portfolio
0.09%
Previous 0.09%
Shares
24 transactions
Others Institutions Holding ASND
# of Institutions
244Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.36 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$717 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$697 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$616 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$585 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.8B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...